nomifensine has been researched along with Adenoma in 24 studies
Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.
Adenoma: A benign epithelial tumor with a glandular organization.
Excerpt | Relevance | Reference |
---|---|---|
"A group of 17 hyperprolactinemic women was given 200 mg of nomifensine orally to evaluate its diagnostic potential to discriminate between tumors and nontumorous hyperprolactinemia." | 7.66 | Nomifensine test does not differentiate hyperprolactinemia associated with and without radiologic abnormalities in the sella turcica. ( Ablanedo, J; Canales, ES; Cano, C; Zárate, A, 1981) |
"To verify the diagnostic capacity of some dynamic tests of the prolactin (Prl) secretion, the findings obtained by high-resolution computed tomography (CT) were compared with results obtained from tests using nomifensine (NOM) domperidone (DOM) and thyrotrophin-releasing hormone (TRH) in 72 patients with pathological hyperprolactinaemia." | 3.67 | Comparison between pituitary computed tomographic findings and tests of hypothalamo-pituitary function in 72 patients with hyperprolactinaemia. ( Bianchi, SD; Camanni, F; Ciccarelli, E; Gatti, G; Ghigo, E; Massara, F; Molinatti, GM; Müller, EE, 1986) |
" Twenty-six women diagnosed by dynamic tests and radiologic examination as having PRL-secreting adenoma were treated surgically (15) or with bromocriptine (11) and their condition was evaluated one to three years later by TRH, nomifensine, and domperidone tests." | 3.67 | Prolactin secretion after surgery or bromocriptine treatment of prolactinoma. ( D'Antona, N; Danero, S; De Leo, V; Genazzani, AR; Petraglia, F; Sardelli, S, 1987) |
"A group of 17 hyperprolactinemic women was given 200 mg of nomifensine orally to evaluate its diagnostic potential to discriminate between tumors and nontumorous hyperprolactinemia." | 3.66 | Nomifensine test does not differentiate hyperprolactinemia associated with and without radiologic abnormalities in the sella turcica. ( Ablanedo, J; Canales, ES; Cano, C; Zárate, A, 1981) |
"Nomifensine has recently been proposed as a dynamic test to discriminate tumoral from functional hyperprolactinaemia." | 1.26 | Some critical considerations on the use of the nomifensine test in the hyperprolactinaemic syndrome. ( Aliffi, A; D'Agata, R; Gulizia, S; Mongioì, A; Vicari, E; Volpicelli, D, 1981) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ferrari, C | 2 |
Romussi, M | 1 |
Benco, R | 1 |
Rampini, P | 2 |
Mailland, F | 1 |
Camanni, F | 5 |
Ghigo, E | 2 |
Ciccarelli, E | 2 |
Massara, F | 4 |
Campagnoli, C | 1 |
Molinatti, G | 1 |
Müller, EE | 8 |
Cocchi, D | 4 |
Novelli, A | 1 |
Ganzetti, I | 1 |
De Leo, V | 5 |
Franchi, F | 1 |
Danero, S | 2 |
Ricci, MG | 1 |
La Marca, S | 2 |
Urbani, TM | 2 |
Pieroni, ML | 1 |
D'Antona, N | 2 |
Genazzani, AR | 6 |
Canales, ES | 1 |
Cano, C | 1 |
Ablanedo, J | 1 |
Zárate, A | 1 |
Murru, S | 2 |
De Gennes, JL | 1 |
Turpin, G | 1 |
Heshmati, HM | 1 |
Carayon, A | 1 |
Pontiroli, AE | 2 |
Loda, G | 1 |
Roggia, A | 1 |
Scagliola, P | 1 |
Falsetti, L | 2 |
Massafra, C | 1 |
De Leo, M | 1 |
Venturi, C | 1 |
Abraham, G | 1 |
Crosignani, PG | 1 |
Caldara, R | 1 |
Picciotti, MC | 1 |
Malinverni, A | 1 |
Barattini, B | 1 |
Telloli, P | 1 |
Molinatti, GM | 3 |
Moriondo, P | 1 |
Travaglini, P | 1 |
Nissim, M | 1 |
Faglia, G | 1 |
D'Agata, R | 1 |
Aliffi, A | 1 |
Vicari, E | 1 |
Volpicelli, D | 1 |
Mongioì, A | 1 |
Gulizia, S | 1 |
Kamoi, K | 1 |
Tchuchida, I | 1 |
Sato, H | 1 |
Tanaka, R | 1 |
Ishiguro, T | 1 |
Kaneko, K | 1 |
Iwasaki, Y | 1 |
Shibata, A | 1 |
Gullo, D | 1 |
Carmina, E | 1 |
Mogavero, G | 1 |
Perino, A | 1 |
Venezia, R | 1 |
Genazzani, A | 1 |
Takeda, R | 1 |
Minagawa, F | 1 |
Nakabayashi, H | 1 |
Bianchi, SD | 1 |
Gatti, G | 1 |
Petraglia, F | 1 |
Sardelli, S | 1 |
Barbarino, A | 1 |
De Marinis, L | 1 |
Mancini, A | 1 |
Menini, E | 1 |
D'Amico, C | 1 |
Passeri, M | 1 |
Sambo, P | 1 |
Anile, C | 1 |
Maira, G | 1 |
Peñalva, A | 1 |
Torpia, R | 1 |
Rossi, GL | 1 |
1 review available for nomifensine and Adenoma
Article | Year |
---|---|
[Differential diagnosis of hyperprolactinemia].
Topics: Adenoma; Bromocriptine; Diagnosis, Differential; Humans; Hyperprolactinemia; Levodopa; Nomifensine; | 1986 |
23 other studies available for nomifensine and Adenoma
Article | Year |
---|---|
Effect of dihydroergocristine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic, and acromegalic subjects: further evidence for pituitary dopamine deficiency in these conditions.
Topics: Acromegaly; Adenoma; Adolescent; Adult; Amenorrhea; Dihydroergotoxine; Dopamine; Female; Growth Horm | 1983 |
Defective regulation of prolactin secretion after successful removal of prolactinomas.
Topics: Adenoma; Adult; Domperidone; Female; Humans; Male; Nomifensine; Pituitary Neoplasms; Pregnancy; Prol | 1983 |
In vivo supersensitivity of the anterior pituitary of old female rats to dopaminergic inhibition of prolactin secretion.
Topics: Adenoma; Animals; Bromocriptine; Dopamine Antagonists; Female; Isoquinolines; Kinetics; Nomifensine; | 1984 |
[Various aspects of dopaminergic function in patients with prolactin-secreting hypophyseal adenoma].
Topics: Adenoma; Adult; Amenorrhea; Carbidopa; Dopamine; Female; Humans; Levodopa; Nomifensine; Pituitary Ne | 1983 |
Nomifensine test does not differentiate hyperprolactinemia associated with and without radiologic abnormalities in the sella turcica.
Topics: Adenoma; Adult; Diagnosis, Differential; Female; Humans; Hyperprolactinemia; Nomifensine; Pituitary | 1981 |
Dynamic tests of prolactin secretion in hyperprolactinemic states: carbidopa-L-dopa and indirectly acting dopamine agonists.
Topics: Adenoma; Adult; Carbidopa; Dopamine; Female; Humans; Kinetics; Levodopa; Methylphenidate; Nomifensin | 1982 |
[Progress in the hormonal detection of pituitary prolactin adenoma].
Topics: Adenoma; Bromocriptine; Domperidone; Humans; Metoclopramide; Nomifensine; Pituitary Neoplasms; Prola | 1982 |
Benserazide and nomifensine in the diagnosis of prolactin-secreting pituitary adenomas.
Topics: Adenoma; Benserazide; Female; Humans; Hydrazines; Isoquinolines; Nomifensine; Pituitary Neoplasms; P | 1982 |
[Indirect dopamine agonists and direct dopamine antagonists in the diagnosis of hyperprolactinemia].
Topics: Adenoma; Adult; Domperidone; False Negative Reactions; False Positive Reactions; Female; Humans; Iso | 1982 |
Use of bromocriptine as a diagnostic and therapeutic tool in hyperprolactinemic states.
Topics: Adenoma; Adolescent; Adult; Amenorrhea; Bromocriptine; Child; Female; Galactorrhea; Humans; Lactatio | 1982 |
Failure of nomifensine administration to discriminate between tumorous and nontumorous hyperprolactinemia.
Topics: Adenoma; Adolescent; Adult; Amenorrhea; Diagnosis, Differential; Female; Galactorrhea; Humans; Isoqu | 1980 |
Tests of prolactin secretion in the diagnosis of hyperprolactinemic states: nomifensine and domperidone.
Topics: Adenoma; Adult; Benzimidazoles; Domperidone; Female; Humans; Isoquinolines; Male; Menstruation; Midd | 1981 |
Evaluation of two inhibitory tests (nomifensine and L-dopa + carbidopa) for the diagnosis of hyperprolactinaemic states.
Topics: Adenoma; Adolescent; Adult; Carbidopa; Diagnosis, Differential; Female; Humans; Isoquinolines; Levod | 1980 |
Some critical considerations on the use of the nomifensine test in the hyperprolactinaemic syndrome.
Topics: Adenoma; Adolescent; Adult; Clinical Laboratory Techniques; Diagnosis, Differential; Female; Humans; | 1981 |
Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors.
Topics: Adenoma; Adult; Female; Humans; Hypothalamic Neoplasms; Isoquinolines; Male; Middle Aged; Nomifensin | 1981 |
Nomifensine in the diagnosis of hyperprolactinemia.
Topics: Adenoma; Adolescent; Adult; Female; Humans; Isoquinolines; Nomifensine; Pituitary Neoplasms; Prolact | 1981 |
Biochemical diagnosis of prolactinoma.
Topics: Adenoma; Female; Humans; Nomifensine; Paraneoplastic Endocrine Syndromes; Pituitary Gland, Anterior; | 1979 |
Nomifensine: diagnostic test in hyperprolactinemic states.
Topics: Adenoma; Female; Humans; Isoquinolines; Lactation; Nomifensine; Pituitary Neoplasms; Postpartum Peri | 1978 |
Comparison between pituitary computed tomographic findings and tests of hypothalamo-pituitary function in 72 patients with hyperprolactinaemia.
Topics: Adenoma; Adolescent; Adult; Domperidone; Female; Humans; Hyperprolactinemia; Hypothalamo-Hypophyseal | 1986 |
Prolactin secretion after surgery or bromocriptine treatment of prolactinoma.
Topics: Adenoma; Adult; Bromocriptine; Domperidone; Female; Humans; Hypophysectomy; Nomifensine; Pituitary N | 1987 |
Prolactin dynamics in patients with non-secretin tumours of the hypothalamic-pituitary region.
Topics: Adenoma; Adenoma, Chromophobe; Adolescent; Adult; Craniopharyngioma; Female; Follicle Stimulating Ho | 1985 |
Persistence of a defective tuberoinfundibular dopaminergic function in rats after long-term removal of oestrogen treatment. An in vivo study.
Topics: Adenoma; Animals; D-Ala(2),MePhe(4),Met(0)-ol-enkephalin; Domperidone; Estradiol; Female; Hypothalam | 1985 |
More on nomifensine.
Topics: Adenoma; Female; Humans; Hyperprolactinemia; Nomifensine; Pituitary Neoplasms | 1985 |